Clomiphene Citrate
An FDA-approved selective estrogen receptor modulator used to induce ovulation in women with infertility.
Medications & hormones
Research records
Historical source snapshot. Not freshly verified, not a recommendation. Study findings, community accounts and app defaults are not interchangeable.
Publication suitability · 2026-10-15: Historical reference only; not a clinical verification. Clinical, regulatory, efficacy, safety and dose claims are not independently established by this review.
Clomiphene Citrate
An FDA-approved selective estrogen receptor modulator used to induce ovulation in women with infertility.
Evidence category: Regulator / guideline. This describes the source category, not approval or certainty.
Regulatory statement in source: FDA-approved.
Clomiphene citrate is an FDA-approved selective estrogen receptor modulator (SERM) approved on February 1, 1967, for treatment of ovulatory dysfunction in women desiring pregnancy. It induces ovulation in patients with anovulatory or oligo-ovulatory infertility and is commonly used in polycystic ovarian syndrome and other causes of infertility. Six-month live birth rate ranges from 20-40%.
Benefits reported in the imported source
- Ovulation induction in women with anovulatory or oligo-ovulatory infertility.
- Widely used for PCOS-related infertility
Risks and limits
- Ovarian hyperstimulation syndrome
- Multiple pregnancy risk
- Visual disturbances
- Mood changes
Source bottom line: FDA-approved SERM for fertility with documented efficacy and established safety profile when used under medical supervision.
Uncertainty: Reference information only. Not medical advice.
Study protocols — reports, not instructions
Women with anovulatory or oligo-ovulatory infertility
- Reported regimen
- Oral administration for ovulation induction
- Duration
- Typical course spans multiple cycles
- Reported outcome
- Induces ovulation; six-month live birth rates of 20-40% reported
- Source
- Clomiphene citrate at 50: the dawning of assisted reproduction (availability check 2026-10-15: source not retrieved; HTTP 403)
Claim provenance
evidence.json#/catalog:hormone:clomiphene-citrate/protocols/0
Community and practice descriptions
Accounts of a practice are not evidence of safety or effectiveness. Words such as “standard”, “safe” or “recommended” describe the source account, not verified consensus or this wiki’s advice. Commercial and self-published citations are retained for traceability, not vendor endorsement or independent clinical corroboration.
Unverified imported account — Clomid (Clomiphene Citrate) - EliteFitness Steroid Profiles
An imported authored paraphrase, not a quotation or a recommended protocol.
Review: unverified historical account. The imported wording is preserved for attribution; its full clinical, dosing, efficacy or consensus claims have not been independently established. Unvalidated source account; no validated human dosing population or animal-to-human equivalence is inferred.
Imported wording: A steroid community profile documents athletic use protocols ranging from 50-100 mg daily for 4-6 weeks, while medical protocols vary from 300 mg on day 1 followed by 100 mg daily for 10 days, then 50 mg daily.
Pharmacokinetic context
No half-life recorded in this source snapshot. No value has been inferred.
Source references
- Clomid (clomiphene citrate) Label - FDA
- Clomiphene - StatPearls (availability check 2026-10-15: possible access barrier; not independently inspected; HTTP 200)
- Clomiphene citrate at 50: the dawning of assisted reproduction (availability check 2026-10-15: source not retrieved; HTTP 403)
Snapshot provenance
Source ID: catalog:hormone:clomiphene-citrate. Commit: adc7684614f9439b41d91a3312b62e7982c7e20e. Review state: historical-not-reverified. Authored links are retained separately from the canonical evidence links in the public data. App templates/defaults and rejected drafts are archived, not deployed.
Related entries and components
None listed.